Panacea Biotec Ltd.

₹362

- 6.60 (-1.79%)

04:01 pm - close price

BSE: PANACEABIO

NSE: PANACEABIO

Industry: Pharmaceuticals & Drugs

House: Soshil Kumar Jain

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -1.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -0.47Good: 20

❌

Current Ratio

Bad: 1Current: 1.49Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -1.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 1.71Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -1.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -0.47Good: 20

❌

Current Ratio

Bad: 1Current: 1.49Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -1.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 1.71Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	129.19	143.02	150.50	136.46	115.72
Expenditure+	139.50	146.58	150.65	142.50	129.71
Other Income+	6.08	3.23	5.68	10.81	3.80
Operating Profit	-10.31	-3.56	-0.15	-6.04	-13.99
Interest	1.00	0.91	0.85	0.82	0.87
Depreciation and Amortization	9.48	9.31	9.11	8.81	8.73
Profit Before Tax	13.03	-7.78	-1.65	-2.12	-17.05
Tax+	2.05	0.51	0.55	-0.13	-1.17
Net Profit	10.98	-8.29	-2.20	-1.99	-15.88

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6248.05	6612.32	4599.46	5591.68	5590.94
Operational Expenses+	5481.76	6744.35	5579.05	5792.29	5850.06
Operating Profit	766.29	-132.03	-979.59	-200.61	-259.12
Other Income	99.77	109.69	516.63	257.96	206.60
OPM %	12.26	-2.00	-21.30	-3.59	-4.63
Depreciation and Amortisation	455.94	437.77	391.23	367.11	348.14
Interest	1853.35	1808.39	44.37	35.81	38.76
Profit Before Tax	-1442.46	14493.56	128.05	14.77	-79.48
Tax	19.57	3710.22	465.50	29.82	7.71
Net Profit	-1476.96	10783.15	-332.37	-11.73	-83.70

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	11773.85	17351.18	14426.41	14122.96	13012.27
Liabilities+	11773.85	17351.18	14426.41	14122.96	13012.27

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1067.64	-1084.48	-4224.52	34.68	-273.69
Cash from Investing Activity	-476.79	12825.73	4303.31	66.59	649.84
Cash from Financing Activity	-471.10	-11758.41	-183.73	-28.08	-26.64
Net Cash Flow	119.75	-17.16	-104.94	73.19	349.51
Opening Cash & Cash Equivalents	402.18	520.79	503.50	398.52	471.74
Closing Cash & Cash Equivalents	520.79	503.50	398.52	471.74	821.25

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	72.48	72.48	72.48	72.48	72.49	72.87	73.46	73.59	73.59	73.59
Public+	27.52	27.52	27.52	27.52	27.51	27.13	26.54	26.41	26.41	26.41
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	34597	33593	34256	33593	35446	39982	45513	46242	47091	48878

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6248.05	6612.32	4599.46	5591.68	5590.94
Operational Expenses+	5481.76	6744.35	5579.05	5792.29	5850.06
Operating Profit	766.29	-132.03	-979.59	-200.61	-259.12
Other Income	99.77	109.69	516.63	257.96	206.60
OPM %	12.26	-2.00	-21.30	-3.59	-4.63
Depreciation and Amortisation	455.94	437.77	391.23	367.11	348.14
Interest	1853.35	1808.39	44.37	35.81	38.76
Profit Before Tax	-1442.46	14493.56	128.05	14.77	-79.48
Tax	19.57	3710.22	465.50	29.82	7.71
Net Profit	-1476.96	10783.15	-332.37	-11.73	-83.70

Ratios

Reported EPS

Bad: 2Current: -1.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -0.47Good: 20

❌

Current Ratio

Bad: 1Current: 1.49Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -1.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 1.71Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -1.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -1.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -0.47Good: 20

❌

Current Ratio

Bad: 1Current: 1.49Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -1.04Good: 15

❌

Debt to Total Assets

Bad: 1Current: 1.71Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1067.64	-1084.48	-4224.52	34.68	-273.69
Cash from Investing Activity	-476.79	12825.73	4303.31	66.59	649.84
Cash from Financing Activity	-471.10	-11758.41	-183.73	-28.08	-26.64
Net Cash Flow	119.75	-17.16	-104.94	73.19	349.51
Opening Cash & Cash Equivalents	402.18	520.79	503.50	398.52	471.74
Closing Cash & Cash Equivalents	520.79	503.50	398.52	471.74	821.25

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	129.19	143.02	150.50	136.46	115.72
Expenditure+	139.50	146.58	150.65	142.50	129.71
Other Income+	6.08	3.23	5.68	10.81	3.80
Operating Profit	-10.31	-3.56	-0.15	-6.04	-13.99
Interest	1.00	0.91	0.85	0.82	0.87
Depreciation and Amortization	9.48	9.31	9.11	8.81	8.73
Profit Before Tax	13.03	-7.78	-1.65	-2.12	-17.05
Tax+	2.05	0.51	0.55	-0.13	-1.17
Net Profit	10.98	-8.29	-2.20	-1.99	-15.88

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	11773.85	17351.18	14426.41	14122.96	13012.27
Liabilities+	11773.85	17351.18	14426.41	14122.96	13012.27

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	72.48	72.48	72.48	72.48	72.49	72.87	73.46	73.59	73.59	73.59
Public+	27.52	27.52	27.52	27.52	27.51	27.13	26.54	26.41	26.41	26.41
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	34597	33593	34256	33593	35446	39982	45513	46242	47091	48878

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Panacea Biotec Ltd.

₹362

- 6.60 (-1.79%)

04:01 pm - close price

BSE: PANACEABIO

NSE: PANACEABIO

Industry: Pharmaceuticals & Drugs

House: Soshil Kumar Jain

Overview